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Abstract 
Purpose: To investigate the inhibitory effects of okra (Abelmoschus esculentus Linn.) extract on the 
production of reactive oxygen species (ROS) and pro-inflammatory cytokines in lipopolysaccharide 
(LPS)-stimulated BV2 microglia. 
Methods: Okra was extracted with ethanol by Soxhlet extraction.  Non-cytotoxic doses of okra at 
concentrations of 50, 100 and 200 μg/mL were used in this study. BV2 cells were cultured and treated 
with LPS in the presence or absence of okra at the concentrations indicated above. ROS, nitric oxide 
(NO), tumor necrotic factor alpha (TNF-α), interleukin 1 beta (IL-1β), phosphorylation levels of nuclear 
factor-kappa B (NF-kB) p65 and Akt were determined. 
Results: Treatment of BV2 cells with okra concentrations of 50, 100 and 200μg/mL significantly 
suppressed LPS-induced NO as well as ROS compared to untreated cells. There was also a significant 
decrease in the production of TNF-α and IL-1β in okra-treated BV2 microglia cells. The level of LPS-
induced NF-kB p65 phosphorylation was significantly decreased by okra treatment. In addition, okra 
inhibited LPS-induced Akt phosphorylation, which is an upstream molecule of NF-kB.  
Conclusion: Okra exerts anti-oxidative and anti-inflammatory effects in LPS-stimulated BV2 microglial 
cells by suppressing Akt-mediated NF-κB pathway. This suggests that okra might be a valuable agent 
for the treatment of anti-neuroinflammatory diseases mediated by microglial cells.  
 
Keywords: Abelmoschus esculentus Linn, Inflammatory cytokines, Lipopolysaccharide, 
Neuroinflammation, Microglia, Reactive oxygen species 
 
Tropical Journal  of Pharmaceutical Research is indexed by Science Citation Index (SciSearch), Scopus, 
International Pharmaceutical Abstract, Chemical Abstracts, Embase, Index Copernicus, EBSCO, African 
Index Medicus, JournalSeek, Journal Citation Reports/Science Edition, Directory of Open Access Journals 




Microglia, the resident immune cells located in 
the central nervous tissue (CNS), play an 
important role in CNS homeostasis during 
development, adulthood and ageing. In their 
resting state, they vigilantly monitor the health of 
neurons. In the event of brain damage or 
infection, microglia are activated, migrate to the 
site of injury, proliferate and phagocytose cells 
and cellular compartments. However, over-
activation of microglia could contribute to 
neuronal cell death as seen in many 
neurodegenerative diseases [1]  due to the 
secretion of inflammatory mediators and 
neurotoxic factors such as nitric oxide (NO), 
interleukin 1 beta (IL-1), tumor necrotic factor 
alpha (TNF-), and reactive oxygen species 
(ROS) [2,3].  
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One transcription factor that plays a significant 
role in the inflammatory response of activated 
microglia is the inducible nuclear factor-kappa B 
(NF-B) [4].  NF-kB exists in the cytoplasm in an 
inactive form associated with regulatory proteins 
called inhibitors of kB (IkB). Inducible NF-κB 
activation depends on phosphorylation-induced 
proteosomal degradation of the inhibitor of IκBs, 
resulting in the nuclear translocation of NF-B. 
The transcription activity of NF-B can be 
regulated by several kinases, including PI3K/Akt 
and ERK signaling pathways [5]. Therefore, 
chemical compounds that can inhibit microglial 
activation through NF-B/PI3K/Akt/ERK signaling 
pathways will result in neuroprotection. 
 
Okra, Abelmoschus esculentus (L.) Monech (also 
known as gumbo or lady’s finger), belongs to the 
family Malvaceae. It plays an important role in 
the human diet, supplying many nutrients. Okra 
seeds are rich in various flavonoids including 
oligomeric catechins, quercetin, and rutin. 
Previous studies reported that okra possesses 
hepatoprotective [6], antidiabetic and  anticancer 
[7] activities.  In addition, it has been reported 
that okra treatment reverses cognitive deficits 
and protect against morphological changes in the 
CA3 region of dexamethasone-treated mice [8]. 
Okra extract and its bioactive constituents, 
quercetin and rutin, also protect neuronal 
function and improve learning and memory 
deficits in dexamethasone-treated mice [9]. 
Recently, we demonstrated that okra treatment 
decreases ROS and H2O2 production, tau 
phosphorylation, and cellular events associated 
with AD in a stably expressed HFE 
neuroblastoma SH-SY5Y cell line [10]. However, 
the role of okra in microglial activation has not 
yet been studied. In this study, the effects of okra 
extract on oxidative and inflammatory responses 
in LPS-induced stimulation of murine BV2 






All the cell culture reagents were purchased from 
Hyclone (South Logan, UT). LPS was purchased 
from Sigma (St. Louis, MO). The BCA protein 
assay kit was obtained from Pierce (Rockford, IL, 
USA), IL-1 and TNF-  ELISA kits were 
purchased from Cell Biolab (San Diego, CA), and 
the ROS detection kit was purchased from 
Calbiochem (La Jolla, CA). The Griess reagent 
kit for nitrite determination was purchased from 
Molecular Probes (Eugene, OR). NF-B p65, p-
NF-B p65, Akt and phosphor-Akt antibody were 
purchased from Santa Cruz Biotechnology 
(Santa Cruz, CA, USA). 
Collection and preparation of okra extract 
 
Okra fruits were collected in January 2014 at 
Maha Sarakham Province, Thailand and 
identified by using the Taxonomic literature 
(Flora of China) [11]. A voucher specimen (no. 
MSUT-6736) was deposited at MSUT 
(Mahasakham University Thailand). Okra 
extraction was carried out according to a 
previously reported method [8]. Briefly, okra was 
dried at 60 °C for 24 h in a hot air oven. Dried 
okra was ground in a blender and subjected to 
Soxhlet extraction using ethanol as the solvent. 
Fifty grams of okra and 200 ml of ethanol were 
used in the extraction. Triplicate extractions were 
performed. The solvent was vacuum-distilled at 
60 °C in a rotary evaporator and the remaining 
extract was dried at room temperature for several 





Murine BV2 microglial cell line was cultured in 75 
cm2 flasks with DMEM supplemented with 5 % 
FBS containing 100 units/mL penicillin and 100 
μg/mL streptomycin, and maintained in a 5 % 
CO2 incubator at 37 °C.  In assays of cell 
viability, NO levels and ROS levels, BV2 cells 
were plated at a density of 1x104 cells/well in 96 
well-plates. In assays seeking to determine TNF-
α and IL-1β production, BV2 cells were plated at 
density of 1 x 105 cells/well in 24 well-plates.  To 
determine Akt, p-Akt, NF-κB p65 and phosphor 
NF-κB p65 levels, cells were plated at a density 1 
x 106 cells/well in 6 well-plates.  Cells were 
cultured as described above and incubated for 
24 h.  At the start of each experiment, the growth 
medium in each well was completely removed 
and replaced with medium containing LPS with 
or without the specified concentrations of okra 
extract  (50, 100, 200 μg/mL) or quercetin (12 
μM) in serum-free medium. 
 
Cell viability assay 
 
MTT (3-(4, 5-dimethylthiazol-2-yl)-2, 5-
diphenyltetrazolium bromide, Sigma-Aldrich, St. 
Louis, MO) assay was used to quantify cell 
viability and cytotoxicity. After 24 h of treatment, 
medium was removed from each well and 
replaced with 0.1 mL of MTT reagent (0.5 
mg/mL) in serum free DMEM. Cells were 
incubated for 2 h at 37 °C. After 2 h of treatment, 
MTT reagent was removed, the formazan dye 
was dissolved with DMSO, and absorption was 
read at 570 nm using a Synergy-4 plate reader 
(BioTek Instruments, Inc., Fisher Scientific, St. 
Louis, MO). 
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Nitric oxide assay 
 
After 24 h of treatment, the level of NO in the 
supernatant was estimated with Griess reagent 
according to the manufacturer’s protocol.  
 
Determination of intracellular reactive oxygen 
species  
 
Cells were seeded in 96-well plates and cultured 
as described above. After 24 h, the cells were 
incubated with 10 μM CM-H2DCFDA for 30 min 
at 37 oC in a CO2 incubator.  Then, cells were 
washed with PBS and treated with LPS in the 
presence or absence of okra extracts or 
quercetin in serum-free medium for 24 h. The 
fluorescence intensity of DCF was measured at 
488 nm excitation and 520 nm emission on a 
Synergy HT Multi-Mode microplate reader 
(BioTek instruments, Winooski, VT). 
 
Enzyme linked immunosorbent assay (ELISA)  
 
Cells in 24 well-plates were treated as described 
above. After 24 h of treatment, the levels of IL-1β 
and TNF-α in supernatants were quantified using 
ELISA kits according to the manufacturer’s 
protocol. 
 
Western blot analysis 
 
After treatment, whole cell protein lysates were 
prepared in a lysis buffer. The total protein 
concentrations in samples were determined 
(Pierce, Rockford, IL, USA).  The total protein 
from each sample was separated by 10 % SDS-
PAGE and transferred to a nitrocellulose (NC) 
membrane (Bedford, MA, USA).  Also, the 
membranes were blocked in 5 % BSA and 0.1 % 
Tween-20 at room temperature for 1 h and 
incubated overnight at 4 °C with antibodies 
against Akt, p-Akt, NF-κB p65, phosphor NF-κB 
p65 and β-actin.  The blots were washed thrice 
and incubated with secondary antibody coupled 
to horseradish peroxidase.  The protein bands 
were detected using Supersignal West Pico 




All the data are expressed as mean  SEM at 
three independent experiments performed in 
triplicate (9 replicates for each value).  Multiple 
comparison of data was carried out by one-way 
ANOVA followed by Bonferroni post-tests.  P < 




Effect of okra and quercetin on cell viability 
of BV2 cells 
 
MTT assay was used to determine the 
cytotoxicity of okra and quercetin on BV2 cells. 
The results show that, at concentrations up to 
200 μg/mL of Okra and 12 μM of quercetin, 
neither okra nor quercetin exhibited toxicity 
against BV2 cells (Figure 1A and Figure 1B). 
Therefore, non-cytotoxic doses of okra (50, 100 
and 200 μg/mL) and quercetin (6 and 12 μM) 
were used in this study. 
 
Effect of okra and quercetin on LPS-induced 
NO production 
 
In order to investigate the role of okra as an anti-
inflammatory mediator, the effects of okra on 
LPS-induced NO production were examined. 
After 24 h of treatment with okra, NO production 
slightly decreased compared to the untreated 
cells (Figure 2A).  After the treatment with LPS, 
NO production was significantly elevated 
 
 
Figure 1: Effect of okra (A) and quercetin (B) on the viability of BV2 microglial cells. Data represent mean ± SEM 
(n = 3); *p < 0.05 when compared with control group; #p < 0.05 when compared with LPS-treated group 
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compared to untreated cells. However, okra 
treatment significantly decreased LPS-induced 
NO production in a concentration-dependent 
manner (50, 100 and 200 μg/mL.)  Since 
quercetin is a constituent of okra and has been 
reported to decrease NO in various models, we 
investigated the effect of this compound also.  As 
with okra, treatment with quercetin significantly 
reduced the level of NO in a concentration-
dependent manner (Figure 2B), returning the 
elevated NO level to that seen in control cells. 
 
Effect of okra and quercetin on ROS 
production 
 
The antioxidant effect of okra on activated 
microglia was investigated by measuring ROS 
production.  After 24 h treatment with okra, ROS 
level significantly decreased compared to 
untreated cells. After the treatment with LPS, the 
ROS level was significantly increased compared 
to untreated cells.  When cells were treated with 
okra in the presence of LPS, there was a 
concentration-dependent attenuation in ROS 
production (Figure 3A). The ROS level also 
decreased significantly after treatment with 
quercetin compared with the untreated control 
group. Furthermore, in cells stimulated with LPS, 
quercetin treatment attenuated LPS-induced 
ROS production in a concentration-dependent 
manner (Figure 3B). 
 
Effect of okra and quercetin on LPS-induced 
TNF-α and IL-1β production 
 
To analyze the anti-inflammatory properties of 
okra on LPS-stimulated BV2 microglial cells, 
production of TNF-α and IL-1β in the cell culture 
media was measured by ELISA. The results 
showed that TNF-α and IL-1β production 
increased significantly after LPS treatment. 
 
Treatment with okra suppressed LPS-induced 
TNF-α and IL-1β production (Figure 4A) in a 
concentration-dependent manner. Quercetin 
treatment also attenuated LPS-induced TNF-α 
and IL-1β production, again in a concentration-
dependent manner (Figure 4B). 
 
Figure 2: Effect of okra (A) and quercetin (B) on NO production induced by LPS in BV2 microglial cells.  Data 
represent the mean ± SEM (n =3); *p < 0.05 when compared with control group; **p < 0.01 when compared with 




Figure 3: Effect of okra (A) and quercetin (B) on ROS production induced by LPS in BV2 microglial cells.  The 
data represent the means ± SEM (n = 3); *p< 0.05 when compared with control group; **p < 0.01 when compared 
with control group; #p < 0.01 when compared with LPS-treated group; #p < 0.05 when compared with LPS-
treated group 
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Effect of okra and quercetin on LPS-induced 
NF-B activation 
 
The results showed that LPS significantly 
increased the phosphorylation of NF-Bp65 
compared with the untreated cells.  However, 
treatment with okra suppressed LPS-induced 
NF-B p65 phosphorylation (Figure 5). As with 
the okra treatment, quercetin significantly 
attenuated LPS-induced NF-B p65 
phosphorylation (Figure 5). 
 
Effect of okra and quercetin on LPS-induced 
Akt phosphorylation 
 
High levels of Akt phosphorylation were 
observed in LPS-treated cells.  However, 
treatment with either okra or quercetin 
significantly inhibited LPS-induced Akt 
phosphorylation during LPS-induced microglia 




Neuroinflammation mediated by microglia has 
been implicated in the development of 
neurodegenerative diseases [12].  Treatments 
that inhibit microglial activation may therefore be 
effective in treating neurodegenerative diseases. 
NO is a major microglia-derived inflammatory 
mediator, and high levels of this mediator are 
reported to be involved in the onset of 
neurodegenerative diseases such as PD, AD, 
and multiple sclerosis [13]. NO can be converted 
to a number of more reactive derivatives known 
 
Figure 4: Effect of okra and quercetin on LPS-induced IL-1β and TNF-α production. After 24 h of treatment, 
culture media were collected for determination of IL-1β (A) and TNF-α (B) production using the ELISA kits. Data 
represent mean ± SEM (n = 3); *p < 0.05 when compared with control group; **p < 0.01 when compared with 




Figure 5: Effects of okra and quercetin on LPS-induced NF-κB activation. After 24 h of treatment,   total cells 
lysates were collected and levels of anti-p65 and phospho p65 were detected by western blot assay. Levels of 
NF-κB p-p65 were normalized to beta actin. Histograms represent the fold-increase of NF-κB p-p65 relative to 
that of the untreated control. Data represent mean ± SEM (n = 3); *p < 0.05 when compared 
Cheepsunthorn et al 





Figure 6: Effect of okra and quercetin on LPS-induced Akt phosphorylation. After 24 h of treatment,   Total cell 
lysate was collected and levels of anti-Akt and phospho Akt determined by western blot assay.  Levels of p-Akt 
were normalized to beta actin. Histograms represent the fold-increase of p-Akt relative to that of the untreated 
control.  These data represent mean ± SEM (n = 3); *p < 0.05 when compared with control group; **p < 0.01 
when compared with control group; #p < 0.01 when compared with LPS-treated group; #p < 0.05 when compared 
with LPS-treated group 
 
as reactive nitrogen species (RNS) such as 
peroxynitrite NO2, N2O3, and S-nitrosothiols.  
These RNS induce cell death, in part, by 
inhibiting mitochondrial respiration or activation 
of mitochondrial permeability transition, triggering 
neuronal apoptosis or necrosis. [14].  In addition, 
high levels of NO/RNS-induced respiratory 
inhibition result in glutamate release, and 
subsequent excitotoxic death of neuron [15]. 
ROS are highly reactive molecules. Excessive 
production of ROS during environmental stress 
can damage cell structures by causing oxidation 
of proteins,  peroxidation of lipids, and damage to 
nucleic acids, ultimately leading to cell death 
[16].  In addition, ROS also play a critical role in 
enhancing neuroinflammation through the 
activation of redox-sensitive transcriptional 
factors such as NF-κB, resulting in increases in 
the synthesis of the proinflammatory genes IL-1 
and TNF-α which in turn, exacerbates the 
pathologic process in inflammatory CNS 
diseases [17]. Medicinal plants possessing both 
NO- and ROS-inhibitory activities might therefore 
be good candidates for the treatment of 
neuroinflammatory disease. In this study, we 
demonstrated that okra inhibit LPS-induced NO 
production in a concentration-dependent manner.  
Since quercetin is a major constituent of okra 
and has been reported to have antioxidant and 
anti-inflammatory activities, quercetin was 
included as a positive control in this  study. The 
results showed that quercetin treatment 
significantly attenuate LPS-induced NO 
production in a concentration-dependent manner. 
This result is consistent with reports that 
quercetin inhibits LPS-induced NO production 
in BV2 microglial cells [18] as well as in other 
cellular models [19]. The results also 
demonstrated that okra and quercetin treatment 
dramatically decrease LPS-induced ROS levels 
in a concentration-dependent manner. It has 
been reported that quercetin is a major 
constituent of okra that exerts potent antioxidant 
activity in different pathway, including direct 
quenching of ROS, chelation of metal ions and 
inhibition of the activity of oxidases, results 
suggest the ability of okra extract to reduce ROS 
in BV2 cells might be due to the presence of this 
compound. 
 
Inflammatory cytokines such as TNF-α and IL-1β 
also play an important role in the pathogenesis of 
neurodegenerative disorders [20]. Elevated TNF-
α and IL-1β can be considered to be a 
histopathological hallmark of neurological 
diseases [21]. It has been reported that TNF-α 
receptors are widely expressed in the CNS, 
and TNF family ligands are the main inducers of 
apoptosis in the CNS.  Therefore, high levels of 
TNF-α secreted by activated microglia during 
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chronic inflammation may contribute to neuronal 
cell death through the apoptotic pathway [22]. In 
this study, it was demonstrated that okra 
inhibited LPS-induced TNF-α and IL-1β 
production, suggesting that okra has an anti-
inflammatory effect on LPS-activated BV2 
microglial cells.   The result also demonstrated 
that quercetin treatment significantly reduced 
LPS-induced TNF-α and IL-1β production.  This 
result is consistent with reports that quercetin 
lowered levels of IL-1β as well as TNF-α in rat 
adjuvant arthritis and in blood mononuclear cells, 
respectively [23]. These results suggest that okra 
might be a good candidate for suppressing 
inflammatory mediators in neuroinflammatory 
disease. 
 
NF-κB is a transcription factor that plays a critical 
role in regulating inflammatory mediators and 
inflammatory cytokines [4].  Normally, NF-κB 
proteins are present in the cytoplasm in 
association with members of the IκB family of 
inhibitory proteins [24]. After stimulation with 
LPS, NF-κB is activated by phosphorylation, 
leading to increased nuclear translocation and 
the DNA-binding activity of NF-κB in its specific 
promoter regions, resulting in the expression of 
proinflammatory genes.  Therefore, inhibition of 
NF-κB activation represents a potential 
therapeutic strategy for neuroinflamatory 
diseases by inhibiting proinflammatory cytokine 
production.  In this study, we examined the effect 
of okra on LPS-induced NF-κB activation by 
determining levels of phosphorylated NF-κB p65. 
The results showed that okra inhibited LPS-
induced NF-κB activation, based on decreasing 
levels of phosphorylated NF-κB p65.  
 
However, okra could not completely inhibit NF-κB 
activation, suggesting that other transcription 
factors such as AP-1 and CREB may also be 
involved in LPS-mediated transcriptional 
induction. It was also demonstrated that 
quercetin treatment significantly inhibited NF-κB 
activation. This correlates with the finding that 
quercetin treatment inhibits LPS-induced NO 
production in BV2 microglial cells by suppressing 
the NF-κB pathway [25].  A recent study showed 
that LPS-induced NF-κB activation is directly 
regulated by phosphorylation of PI3K/Akt in 
microglial cells [4], so we further investigated the 
effect of okra on LPS-induced Akt 
phosphorylation. These results show that okra 
significantly reduce LPS-induced Akt 
phosphorylation, suggesting that okra-induced 
decreases in production of the inflammatory 
mediator NO, and proinflammatory cytokines 
TNF-α and IL-1β are due, at least in part, to 




The findings of this study demonstrate that okra 
attenuates the production of the proinflammatory 
mediators, NO and ROS, as well as production of 
TNF-α and IL-1β, in LPS-stimulated BV2 
microglial cells by suppressing Akt-mediated NF-
κB pathway.  The findings provide evidence that 
okra possesses potential anti-oxidative and anti-
inflammatory activities in neuronal disorders 
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